Patient-Reported Treatment Satisfaction with Rivaroxaban for Stroke Prevention in Atrial Fibrillation. A French Observational Study, the SAFARI Study

• Olivier Hanon ,

  * E-mail: olivier.hanon@aphp.fr

  Affiliations APHP Hôpital Broca, Service de Gériatrie, Paris, France, Université Paris Descartes, Sorbonne Paris Cité, Paris, France

  ⨯
• Edouard Chaussade,

  Affiliations APHP Hôpital Broca, Service de Gériatrie, Paris, France, Université Paris Descartes, Sorbonne Paris Cité, Paris, France

  ⨯
• Pierre Gueranger,

  Affiliation CH La Chartreuse, Service de Cardiologie, Villefranche de Rouergue, France

  ⨯
• Elise Gruson,

  Affiliation Bayer Healthcare SAS, Loos, France

  ⨯
• Sabrina Bonan,

  Affiliation ICTA Project Management, Fontaine-les-Dijon, France

  ⨯
• Alain Gay

  Current address: Bayer Pharma Aktiengesellschaft, Cardio-, Pulmono- & Infectiology, Berlin, Germany

  Affiliation Bayer Healthcare SAS, Loos, France

  ⨯